Speech-Language Pathologists in Bow, WA Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Ms. Christine H Waddell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5801 Main St, Bow, WA 98232 Phone: 360-757-3375 |
Kathleen Johnson Becker, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17145 Cook Rd, Bow, WA 98232 Phone: 360-757-3352 Fax: 360-757-2503 |
Ellison Arlene Lind, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9939 Sea Crest Ln, Bow, WA 98232 Phone: 360-630-8256 |
News Archive
Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates
A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine.
Surgeon Spotlight Series showcases interview with top orthopaedic surgeons
Allen Medical Systems, a Hill-Rom company, announces the second in its Surgeon Spotlight Series showcasing interviews with top orthopaedic surgeons. Carlos A. Guanche, M.D., managing partner at Southern California Orthopaedic Institute, is the featured surgeon and is recognized for his contributions in expanding the use of the Allen Intraoperative Arm Positioner for elbow fractures, scopes and clavicle repair procedures.
Seattle Genetics reports its third-quarter financial results
Seattle Genetics, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009. The company also highlighted recent product development progress.
XenoPort reports equity awards to new employee under Inducement Award Plan
XenoPort, Inc. reported today that equity awards were made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employee was granted options to purchase an aggregate of 75,000 shares of XenoPort's common stock and restricted stock units representing an aggregate of 5,000 shares of XenoPort's common stock.
CMS report on radiation oncology alternative payment model provides viable path to better cancer care
The American Society for Radiation Oncology today called on the Centers for Medicare and Medicaid Services to move forward urgently with the development of a radiation oncology alternative payment model following a new report to Congress from the Center for Medicare and Medicaid Innovation.
› Verified 6 days ago